Cryo-Cell International (CCEL.US): The 2024 Q1 financial report achieved revenue of $7.85 million, previous value of USD 7.82 million, expected value of USD 7.93 million; earnings per share was USD 0.07, previous value was USD 0.09, and expected value was -0.02 USD.
Cryo-Cell International(CCEL.US)：2024年Q1财报实现营收785万美元，前值为782万美元，预期值为793万美元；每股收益为0.07美元，前值为0.09美元，预期值为-0.02美元。
Cryo-Cell International (CCEL.US): The 2024 Q1 financial report achieved revenue of $7.85 million, previous value of USD 7.82 million, expected value of USD 7.93 million; earnings per share was USD 0.07, previous value was USD 0.09, and expected value was
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.